{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:25:21Z","timestamp":1790508321400,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.kint.2018.01.024","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T01:34:42Z","timestamp":1524792882000},"page":"252-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["The role of cannabinoid signaling in acute and chronic kidney diseases"],"prefix":"10.1016","volume":"94","author":[{"given":"Federica","family":"Barutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Mastrocola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Bellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Gruden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2018.01.024_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.kint.2018.01.024_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1677\/JME-08-0190","article-title":"Signal transduction of the CB1 cannabinoid receptor","volume":"44","author":"Turu","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.kint.2018.01.024_bib3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/mol.114.094649","article-title":"CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?","volume":"86","author":"Dhopeshwarkar","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.kint.2018.01.024_bib4","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/bph.13226","article-title":"Role of the endocannabinoid system in diabetes and diabetic complications","volume":"173","author":"Gruden","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.kint.2018.01.024_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1476-5381.2010.00908.x","article-title":"A\u00a0novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents","volume":"161","author":"Cluny","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.kint.2018.01.024_bib6","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1172\/JCI42551","article-title":"Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity","volume":"120","author":"Tam","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2018.01.024_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2012.07.002","article-title":"Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance","volume":"16","author":"Tam","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.kint.2018.01.024_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","article-title":"Endocannabinoid signaling at the periphery: 50 years after THC","volume":"36","author":"Maccarrone","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.kint.2018.01.024_bib9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2741\/s461","article-title":"Anandamide and its metabolites: what are their roles in the kidney?","volume":"8","author":"Ritter","year":"2016","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.kint.2018.01.024_bib10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/sj.ki.5002540","article-title":"Blockade of cannabinoid CB1 receptor improves renal function, metabolic profile, and increased survival of obese Zucker rats","volume":"72","author":"Janiak","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.01.024_bib11","doi-asserted-by":"crossref","first-page":"E5420","DOI":"10.1073\/pnas.1419901111","article-title":"Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy","volume":"111","author":"Jourdan","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2018.01.024_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/JOE-15-0004","article-title":"Chronic administration of AM251 improves albuminuria and renal tubular structure in obese rats","volume":"225","author":"Jenkin","year":"2015","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.kint.2018.01.024_bib13","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1681\/ASN.2016101085","article-title":"Proximal tubular cannabinoid-1 receptor regulates obesity-induced CKD","volume":"28","author":"Udi","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.01.024_bib14","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2337\/db09-1336","article-title":"Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy","volume":"59","author":"Barutta","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.kint.2018.01.024_bib15","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1210\/en.2011-1423","article-title":"Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db\/db mice","volume":"153","author":"Nam","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.kint.2018.01.024_bib16","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.2337\/db10-1809","article-title":"Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy","volume":"60","author":"Barutta","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.kint.2018.01.024_bib17","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ki.2014.165","article-title":"Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice","volume":"86","author":"Barutta","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.01.024_bib18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/MAJ.0000000000000352","article-title":"Induction of proteinuria by cannabinoid receptors 1 signaling activation in CB1 transgenic mice","volume":"349","author":"Hsu","year":"2015","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.kint.2018.01.024_bib19","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/dom.13150","article-title":"Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy","volume":"20","author":"Jourdan","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.kint.2018.01.024_bib20","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/ndt\/gfx010","article-title":"Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy","volume":"32","author":"Barutta","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.01.024_bib21","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.cellsig.2014.04.008","article-title":"Ubiquitination-dependent CARM1 degradation facilitates Notch1-mediated podocyte apoptosis in diabetic nephropathy","volume":"26","author":"Kim","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.kint.2018.01.024_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000442679","article-title":"Therapy with a selective cannabinoid receptor type 2 agonist limits albuminuria and renal injury in mice with type 2 diabetic nephropathy","volume":"132","author":"Zoja","year":"2016","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2018.01.024_bib23","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12108","article-title":"Acute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats","volume":"2","author":"Schaich","year":"2014","journal-title":"Physiol Rep"},{"key":"10.1016\/j.kint.2018.01.024_bib24","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.biocel.2012.07.008","article-title":"Endocannabinoids and the renal proximal tubule: an emerging role in diabetic nephropathy","volume":"44","author":"Jenkin","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.kint.2018.01.024_bib25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ki.2015.63","article-title":"Cannabinoid receptor 1 is a major mediator of renal fibrosis","volume":"88","author":"Lecru","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.01.024_bib26","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/db16-1199","article-title":"Developmental role of macrophage cannabinoid-1 receptor signaling in type 2 diabetes","volume":"66","author":"Jourdan","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.kint.2018.01.024_bib27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1681\/ASN.2017040371","article-title":"Modulation of renal GLUT2 by the cannabinoid-1 receptor: implications for the treatment of diabetic nephropathy","volume":"29","author":"Hinden","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.01.024_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jdiacomp.2013.08.005","article-title":"Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes","volume":"28","author":"Buraczynska","year":"2014","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.kint.2018.01.024_bib29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00109-014-1125-6","article-title":"Cannabinoid receptor 1 disturbance of PPAR\u03b32 augments hyperglycemia induction of mesangial inflammation and fibrosis in renal glomeruli","volume":"92","author":"Lin","year":"2014","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.kint.2018.01.024_bib30","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1038\/emboj.2011.139","article-title":"AT1R-CB1R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II","volume":"30","author":"Rozenfeld","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.kint.2018.01.024_bib31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1476-5381.2010.00769.x","article-title":"CB1 cannabinoid receptors promote oxidative\/nitrosative stress, inflammation and cell death in a murine nephropathy model","volume":"160","author":"Mukhopadhyay","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.kint.2018.01.024_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.freeradbiomed.2009.11.022","article-title":"Cannabinoid-2 receptor limits inflammation, oxidative\/nitrosative stress, and cell death in nephropathy","volume":"48","author":"Mukhopadhyay","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.kint.2018.01.024_bib33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.etp.2008.04.006","article-title":"The preventive effect of cannabinoids on reperfusion-induced ischemia of mouse kidney","volume":"60","author":"Feizi","year":"2008","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.kint.2018.01.024_bib34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1089\/can.2016.0013","article-title":"Increased renal 2-arachidonoylglycerol level is associated with improved renal function in a mouse model of acute kidney injury","volume":"1","author":"Moradi","year":"2016","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.kint.2018.01.024_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7812\/TPP\/16-160","article-title":"Spice-y kidney failure: a case report and systematic review of acute kidney injury attributable to the use of synthetic cannabis","volume":"21","author":"Zarifi","year":"2017","journal-title":"Perm J"},{"key":"10.1016\/j.kint.2018.01.024_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/7854_2016_60","article-title":"Pharmacological and toxicological effects of synthetic cannabinoids and their metabolites","volume":"32","author":"Tai","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.kint.2018.01.024_bib37","doi-asserted-by":"crossref","first-page":"13958","DOI":"10.1038\/ncomms13958","article-title":"Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity","volume":"8","author":"Soethoudt","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2018.01.024_bib38","doi-asserted-by":"crossref","first-page":"e5844","DOI":"10.1371\/journal.pone.0005844","article-title":"Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis","volume":"4","author":"Deveaux","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.kint.2018.01.024_bib39","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/0960-894X(96)00426-X","article-title":"New class of potent ligands for the human peripheral cannabinoid receptor","volume":"6","author":"Gallant","year":"1996","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.kint.2018.01.024_bib40","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1021\/jm070441u","article-title":"Cannabilactones: a novel class of CB2 selective agonists with peripheral analgesic activity","volume":"50","author":"Khanolkar","year":"2007","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.kint.2018.01.024_bib41","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1124\/jpet.116.236539","article-title":"Two Janus cannabinoids that are both CB2 agonists and CB1 antagonists","volume":"360","author":"Dhopeshwarkar","year":"2017","journal-title":"J\u00a0Pharmacol Exp Ther"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818301406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818301406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:49:57Z","timestamp":1758761397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253818301406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0085253818301406"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2018.01.024","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of cannabinoid signaling in acute and chronic kidney diseases","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2018.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}